Patient Selection for REBOA: Maximizing Benefits, Minimizing Risks

As trauma care evolves, Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) stands at a crossroads. Its potential to save lives is clear, yet its application remains controversial. This piece challenges us to reconsider our approach to REBOA, focusing on the critical – and often overlooked – aspect of patient selection.

The Paradox of REBOA

REBOA presents a challenging paradox in trauma care. Its potential to save lives is clear, yet its application can sometimes lead to complications. This dual nature highlights the critical importance of judicious use. When applied to carefully selected patients, REBOA can be a powerful tool in managing severe hemorrhage. However, for certain patients, it may introduce risks that outweigh its potential benefits. The key lies in identifying those who stand to gain the most from this intervention while minimizing harm to those who may be adversely affected.

This reality pushes us to reconsider how we approach REBOA in clinical practice. It’s not enough to simply have the technology available; we must develop a nuanced understanding of when and how to use it effectively. This requires a careful balance of clinical judgment, evidence-based criteria, and an awareness of each patient’s unique circumstances.

Ideal Candidates: Beyond the Obvious

While hypotensive patients with non-compressible torso hemorrhage are often considered prime candidates, the selection process demands a refined approach. Consider these factors:

1. Physiological Reserve: Patients with robust physiological reserves may better tolerate the ischemia-reperfusion stress of REBOA. Serum lactate levels and base deficit are potential indicators of physiological reserve, though more research is needed to establish definitive thresholds.
2. Injury Pattern: REBOA is most effective for injuries below the diaphragm. Patients with isolated pelvic or abdominal injuries often benefit more than those with multiple injury sites. Particular attention should be given to patients with pelvic fractures associated with hemodynamic instability, as they may be strong candidates for REBOA.
3. Time from Injury: The “golden hour” concept applies here. REBOA’s efficacy may decrease with increased time from injury, though exact timelines remain debated. Rapid deployment of REBOA in appropriate cases is crucial, but further research is needed to establish optimal time windows.
4. Potential for Definitive Care: REBOA should be seen as a bridge to definitive treatment. Patients with injuries amenable to rapid surgical intervention may be ideal candidates. The procedure’s role in buying time for definitive surgical management is a key consideration in patient selection.

Who Shouldn’t Receive REBOA?

Equally important is identifying patients for whom REBOA may do more harm than good:

1. Severe Brain Injuries: REBOA can increase intracranial pressure, potentially exacerbating brain injuries. Caution is warranted when considering REBOA in patients with known or suspected severe traumatic brain injuries.
2. Cardiac Tamponade: In these cases, REBOA may worsen cardiac output and prove counterproductive. Careful cardiac assessment is crucial before REBOA deployment to avoid its use in patients with undiagnosed cardiac tamponade.
3. Thoracic Aortic Injuries: REBOA could catastrophically worsen these injuries. Advanced imaging techniques, such as rapid CT angiography, help rule out thoracic aortic injuries before REBOA deployment.
4. Refractory Cardiac Arrest: While tempting in desperate situations, REBOA’s benefit in patients with prolonged cardiac arrest remains controversial. Its use in this context should be carefully considered against established advanced cardiac life support protocols.
5. Severe Coagulopathy: These patients may face heightened risks of complications from REBOA. Coagulation status should be carefully assessed when considering REBOA, as severe coagulopathy may increase the risk of procedure-related complications.

These contraindications highlight the importance of comprehensive patient assessment before REBOA deployment. The decision to use REBOA should always balance potential benefits against risks, considering the patient’s overall clinical picture and injury pattern.

Challenging Conventional Wisdom

Is our current approach to REBOA too binary? Perhaps we need to view patient selection on a spectrum rather than a yes/no decision. Consider:

1. Partial REBOA: For some patients, partial aortic occlusion might balance hemorrhage control with organ perfusion more effectively than complete occlusion. This approach could potentially reduce the risk of ischemia-reperfusion injuries associated with complete aortic occlusion while still providing hemodynamic support.
2. Intermittent REBOA: Could cyclic inflation/deflation extend the safe duration of REBOA in certain patients? This technique might allow for longer total management times by providing periods of reperfusion, potentially reducing the risk of prolonged ischemia to distal tissues.
3. REBOA as a Diagnostic Tool: In unclear cases, could brief aortic occlusion serve a diagnostic purpose, guiding further treatment decisions? Short-duration REBOA deployment might help assess a patient’s hemodynamic response, providing valuable information for ongoing management strategies.

These alternative approaches to REBOA use are areas of active research and debate within the trauma care community. While promising, they require further investigation to establish their safety and efficacy compared to traditional REBOA techniques. As our understanding evolves, these concepts may help refine and expand the role of REBOA in trauma management.

The Role of Technology in Patient Selection

As REBOA devices evolve, so too should our selection criteria. Newer, smaller catheters are being developed and introduced into clinical practice, which may expand the pool of potential candidates for this procedure. These technological advancements offer the possibility of reduced invasiveness and potentially fewer access site complications.

The trend towards smaller catheter sizes represents an important area of ongoing research and clinical evaluation. These advancements may broaden the application of REBOA, particularly in patients with smaller arterial anatomy, such as women or pediatric patients, who might have been considered unsuitable for the procedure with larger catheters.

Beyond catheter size, automation is playing an increasingly significant role in REBOA technology. Smart balloon inflation systems(1) are being developed to optimize occlusion pressure and duration, potentially reducing the risk of over-inflation and associated complications. These automated systems may allow for more precise control and could expand the use of REBOA to less experienced operators in emergency situations.

Novel access devices are also revolutionizing the REBOA landscape. Some incorporate ultrasound guidance for more accurate placement, while others feature simplified mechanical designs for rapid deployment in austere environments. These innovations aim to address one of REBOA’s most challenging aspects—gaining swift and safe arterial access under stressful conditions.

Additionally, advanced imaging integration is enhancing the precision of balloon placement. Real-time fluoroscopy guidance(2) and emerging augmented reality systems are allowing for more accurate positioning, potentially reducing the risk of inadvertent occlusion of critical vessels.

As these technologies continue to advance, they not only have the potential to expand the pool of REBOA candidates but also to enhance the procedure’s overall safety and efficacy. However, with each new advancement comes the need for updated protocols, training, and careful evaluation of outcomes to ensure that technological progress translates into improved patient care.

Ethical Considerations: The Unspoken Dilemma

Patient selection for REBOA often occurs in high-stress, time-critical situations. This raises ethical questions:

1. How do we balance the potential for immediate life-saving intervention against the risk of severe complications?
2. In resource-limited settings, how do we decide which patients receive this resource-intensive procedure?
3. How do we handle cases where REBOA might save a life but at the cost of severe long-term morbidity, such as a leg amputation?

These ethical dilemmas stress the need for clear protocols and ongoing discussions within the trauma care community. Some institutions have implemented ethics committees specifically for reviewing complex REBOA cases, aiming to balance immediate needs with long-term patient outcomes.

A Call to Action: Improving Our Approach

Optimizing REBOA use demands a multifaceted approach, one that embraces both current best practices and future innovations. At its core, we need dynamic, evidence-based protocols that flex with patient factors, injury patterns, and institutional resources. These guidelines must evolve in lockstep with emerging research, ensuring our approach remains cutting-edge.

But protocols alone aren’t enough. We must revolutionize our training methods, moving beyond mere technical proficiency. By immersing trauma teams in complex, simulated scenarios, we can sharpen their decision-making skills, particularly in patient selection – a critical factor in REBOA’s success.

This push for excellence extends to team composition as well. The most effective REBOA decisions arise from a symphony of expertise—trauma surgeons, emergency physicians, interventional radiologists, and critical care specialists all play crucial roles. Institutions that foster such collaborative environments often witness more nuanced, holistic patient care.

A robust data foundation must underpin these efforts. Comprehensive registries that capture not just outcomes but the intricate decision-making processes behind REBOA use will prove invaluable. These insights will fuel the continuous refinement of our protocols and training methods.

Conclusion: The Path Forward

REBOA’s controversy stems not from the technique itself but from its application. By fine-tuning our approach to patient selection, we can maximize REBOA’s full potential while minimizing its risks. This demands a shift in thinking: from seeing REBOA as a last-resort measure to recognizing it as a precise tool in our trauma care arsenal.

The future of REBOA lies not in wider use but in smarter, more nuanced applications. By questioning our assumptions, grappling with complexity, and steadily refining our methods, we can ensure REBOA serves its true purpose: saving lives without causing undue harm. Moving forward, REBOA’s success will hinge on our ability to pair this powerful technique with the patients who stand to benefit most while safeguarding those for whom the risks outweigh the potential benefits.

References:

1. nces:
   1. McCarthy C, Kanterman I, Trauzettel F, et al. Automated Balloon Control in Resuscitative Endovascular Balloon Occlusion of the Aorta. IEEE Trans Biomed Eng. 2019;66(6):1723-1729. doi:10.1109/TBME.2018.2878642
   2. Vrancken SM, Borger van der Burg BLS, Vrancken PJEM, Kock GH, Rasmussen TE, Hoencamp R. A contemporary assessment of devices for Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): resource-specific options per level of care. Eur J Trauma Emerg Surg. 2021;47(1):57-69. doi:10.1007/s00068-020-01382-5